We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+5.8%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$243M
AUM Growth
-$8.83M
Cap. Flow
-$21M
Cap. Flow %
-8.67%
Top 10 Hldgs %
68.56%
Holding
127
New
18
Increased
18
Reduced
12
Closed
20

Top Buys

Rank Stock Value
1
CLMT icon
Calumet Specialty Products
CLMT
+$6.99M
2
FTAI icon
FTAI Aviation
FTAI
+$4.2M
3
UPLD icon
Upland Software
UPLD
+$4.19M
4
SWBI icon
Smith & Wesson
SWBI
+$3.62M
5
META icon
Meta Platforms (Facebook)
META
+$3.59M

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$33.3M
2
PFE icon
Pfizer
PFE
+$12.4M
3
MSFT icon
Microsoft
MSFT
+$6.16M
4
RXDX
Ignyta, Inc.
RXDX
+$1.81M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$1.3M

Sector Composition

Rank Sector Weight
1 Healthcare 55.53%
2 Technology 8.11%
3 Industrials 7.13%
4 Financials 7.01%
5 Energy 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STML
26
DELISTED
Stemline Therapeutics, Inc.
STML
$1.38M 0.57%
90,000
+15,008
+20% +$234K
AB icon
27
AllianceBernstein
AB
$3.43B
$1.36M 0.56%
50,500
– –
CPRX
28
DELISTED
Catalyst Pharmaceutical
CPRX
$1.17M 0.48%
488,575
+108,465
+29% +$360K
CNCE
29
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$1.14M 0.47%
49,557
– –
VKTX icon
30
Viking Therapeutics
VKTX
$3.75B
$1.06M 0.44%
242,000
+10,000
+4% +$55.3K
ARNA
31
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.03M 0.42%
26,042
+6,000
+30% +$233K
CNQ icon
32
Canadian Natural Resources
CNQ
$101B
$1.02M 0.42%
66,059
– –
RHP icon
33
Ryman Hospitality Properties
RHP
$8.92B
$960K 0.4%
12,400
– –
AIMT
34
DELISTED
Aimmune Therapeutics
AIMT
$948K 0.39%
29,780
+21,749
+271% +$765K
JNJ icon
35
Johnson & Johnson
JNJ
$646B
$933K 0.38%
7,280
– –
APO icon
36
Apollo Global Management
APO
$79.7B
$889K 0.37%
30,000
– –
GSK icon
37
GSK
GSK
$102B
$883K 0.36%
18,080
– –
VZ icon
38
Verizon
VZ
$208B
$876K 0.36%
18,311
– –
XRN.PRA
39
Chiron Real Estate Inc Series A Preferred Stock
XRN.PRA
$78.1M
$861K 0.35%
35,000
– –
IMMU
40
DELISTED
Immunomedics Inc
IMMU
$854K 0.35%
58,483
– –
ZGNX
41
DELISTED
Zogenix, Inc.
ZGNX
$801K 0.33%
20,000
+8,500
+74% +$337K
T icon
42
AT&T
T
$178B
$786K 0.32%
29,194
– –
QTNT
43
DELISTED
Quotient Limited Ordinary Shares
QTNT
$754K 0.31%
4,000
+1,525
+62% +$275K
UAL icon
44
United Airlines
UAL
$35.9B
$695K 0.29%
10,000
– –
AXGN icon
45
Axogen
AXGN
$2.77B
$690K 0.28%
18,898
– –
GILD icon
46
Gilead Sciences
GILD
$181B
$671K 0.28%
8,901
-1,000
-10% -$79.5K
MDLZ icon
47
Mondelez International
MDLZ
$79.6B
$663K 0.27%
15,900
– –
KMB icon
48
Kimberly-Clark
KMB
$36.4B
$661K 0.27%
6,000
– –
IBM icon
49
IBM
IBM
$222B
$657K 0.27%
4,481
– –
SVC
50
Service Properties Trust
SVC
$1.02B
$634K 0.26%
5,000
– –
1
2
3 4 5

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q1 2018 Portfolio in Review

As of Q1 2018, David M. Knott held 127 positions worth $243M, down 3.5% from $251M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

David M. Knott withdrew a net $21M in Q1 2018, closing 20 positions and reducing 12 holdings. Its most notable exit was Ignyta, Inc., an estimated $1.81M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 65% a quarter earlier, followed by Technology and Industrials.

Against the trend, David M. Knott opened a new position in Calumet Specialty Products worth $6.67M.

  • David M. Knott's largest Q1 2018 buy was Calumet Specialty Products: 945,558 shares worth $6.67M.
  • David M. Knott added most to FTAI Aviation in Q1 2018, an estimated $4.2M increase.
  • David M. Knott's biggest Q1 2018 reduction was Ligand Pharmaceuticals, cutting an estimated $33.3M.
  • David M. Knott fully exited Ignyta, Inc. in Q1 2018, selling an estimated $1.81M.
  • David M. Knott's ten largest holdings make up 69% of its $243M portfolio in Q1 2018.
  • David M. Knott opened 18 new positions and closed 20 in Q1 2018.
  • David M. Knott's portfolio value fell 3.5% quarter-over-quarter to $243M.

Based on David M. Knott's 13F filing for Q1 2018, filed 11 May 2018.